These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10974501)

  • 21. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
    Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
    Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [1H-proton magnetic resonance spectroscopy in patients with multiple system atrophy and 
cognitive dysfunction].
    Xiang X; Hou X; Sun Z; Zhou G; Tang B; Jiang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):639-45. PubMed ID: 26164513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
    Davie CA; Wenning GK; Barker GJ; Tofts PS; Kendall BE; Quinn N; McDonald WI; Marsden CD; Miller DH
    Ann Neurol; 1995 Feb; 37(2):204-10. PubMed ID: 7847862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H; Granberg T; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
    Aotsuka A; Shinotoh H; Hattori T
    Nihon Rinsho; 1997 Jan; 55(1):249-54. PubMed ID: 9014459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.
    Kashihara K; Shinya T; Higaki F
    Intern Med; 2011; 50(16):1683-7. PubMed ID: 21841326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
    Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
    PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
    Raffel DM; Koeppe RA; Little R; Wang CN; Liu S; Junck L; Heumann M; Gilman S
    J Nucl Med; 2006 Nov; 47(11):1769-77. PubMed ID: 17079809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of dystonia in atypical parkinsonism.
    Godeiro-Junior C; Felício AC; Barsottini OG; Aguiar PM; Silva SM; Borges V; Ferraz HB
    Arq Neuropsiquiatr; 2008 Dec; 66(4):800-4. PubMed ID: 19099114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.
    Krismer F; Pinter B; Mueller C; Mahlknecht P; Nocker M; Reiter E; Djamshidian-Tehrani A; Boesch SM; Wenning GK; Scherfler C; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2017 Feb; 35():36-41. PubMed ID: 27890451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocturnal manifestations of atypical and vascular parkinsonism: how do they differ from Parkinson's disease?
    Bhidayasiri R; Jitkritsadakul O; Petchrutchatachart S; Kaewwilai L; Panyakaew P; Boonrod N; Colosimo C
    J Neural Transm (Vienna); 2014 Aug; 121 Suppl 1():S69-77. PubMed ID: 24668247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.